Skip to main content
. Author manuscript; available in PMC: 2019 Jun 21.
Published in final edited form as: Neuron. 2018 Feb 7;97(3):611–625.e5. doi: 10.1016/j.neuron.2018.01.037

Figure 2. Screening for modulatory systems regulating Pyr-SST synaptic transmission.

Figure 2.

(A) The -fold change of the first EPSP amplitude in a baseline condition and the following bath-applied agents: forskolin (cell-permeable activator of adenylyl cyclase ); carbachol (a broad-spectrum cholinergic agonist), adenosine; AM-251 (endocannabinoid inhibitors); depolarization-induced suppression of excitation (DSE); DHPG (a metabotropic glutamate receptor antagonist); serotonin; CY 208–243 (D1 receptor agonist) and norepinephrine. (B) The -fold change of the mean failure rate for the same conditions as in (A). Open circles represent individual cell values; bars represent all-cell mean± SEM.